12:00 AM
 | 
Dec 03, 2012
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Validus, Novartis, Wood Creek Capital Management LLC sales and marketing update

Investment manager Wood Creek's U.S. Pharmaceuticals Holdings I LLC subsidiary acquired U.S. rights to six marketed product lines from Novartis. Validus will serve...

Read the full 94 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >